tiprankstipranks
Trending News
More News >
Cocrystal Pharma Inc (COCP)
NASDAQ:COCP
US Market

Cocrystal Pharma (COCP) Financial Statements

Compare
1,030 Followers

Cocrystal Pharma Financial Overview

Cocrystal Pharma's market cap is currently $13.51M. The company's EPS TTM is $-0.19; its P/E ratio is -1.05; Cocrystal Pharma is scheduled to report earnings on November 14, 2025, and the estimated EPS forecast is $-0.17. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 2.01M
Gross Profit$ -12.54M$ -15.17M$ -12.39M$ -8.79M$ -4.02M
Operating Income$ -17.88M$ -18.56M$ -38.83M$ -14.22M$ -9.59M
EBITDA$ -17.75M$ -20.97M$ -17.95M$ -14.03M$ -9.43M
Net Income$ -17.50M$ -17.98M$ -38.84M$ -14.19M$ -9.65M
Balance Sheet
Cash & Short-Term Investments$ 9.86M$ 26.35M$ 37.14M$ 58.70M$ 33.01M
Total Assets$ 13.46M$ 31.26M$ 40.84M$ 79.39M$ 54.24M
Total Debt$ 1.81M$ 1.85M$ 297.00K$ 534.00K$ 596.00K
Net Debt$ -8.05M$ -24.50M$ -36.85M$ -58.17M$ -32.41M
Total Liabilities$ 3.93M$ 4.88M$ 1.27M$ 1.84M$ 1.74M
Stockholders' Equity$ 9.52M$ 26.38M$ 39.57M$ 77.55M$ 52.51M
Cash Flow
Free Cash Flow$ -16.49M$ -14.78M$ -21.51M$ -12.77M$ -10.07M
Operating Cash Flow$ -16.48M$ -14.67M$ -21.43M$ -12.72M$ -9.83M
Investing Cash Flow$ -8.00K$ -118.00K$ -74.00K$ -52.00K$ -240.00K
Financing Cash Flow$ 0.00$ 3.99M$ -27.00K$ 38.47M$ 35.66M
Currency in USD

Cocrystal Pharma Earnings and Revenue History

Cocrystal Pharma Debt to Assets

Cocrystal Pharma Cash Flow

Cocrystal Pharma Forecast EPS vs Actual EPS